Pharmacogenomics - Info and Reading Options

"Pharmacogenomics" Table Of Contents:

• 1- Public attitudes about pharmacogenomics / Mark A. Rothstein and Carlton A. Hornung
• 2- Pharmacogenomics: pharmacology and toxicology in the genomics era / Harvey W. Mohrenweiser
• 3- The implications of population genetics for pharmacogenomics / Craig L. Hanis
• 4- Genome research and minorities / Henry T. Greely
• 5- Drug development strategies / Penelope K. Manasco and Teresa E. Arledge
• 6- Drug development, regulation, and genetically guided therapy / David W. Feigal and Steven I. Gutman
• 7- Intellectual property and commercial aspects of pharmacogenomics / Allen C. Nunnally, Scott A. Brown, and Gary A. Cohen
• 8- Integration of pharmacogenomics into medical practice / Gilbert S. Omenn and Arno G. Motulsky
• 9- Clinical utility of pharmacogenetics and pharmacogenomics / Neil A. Holtzman
• 10- Medical liability for pharmacogenomics
• 11- Larry I. Palmer
• 12- The challenges of pharmacogenomics for pharmacy education / David B. Brushwood
• 13- Economic implications of pharmacogenomics / C.E. Reeder and W. Michael Dickson
• 14- Pharmacogenomics and the social construction of identity / Morris W. Foster
• 15- Pharmacogenomics: considerations for communities of color / Laurie Nsiah-Jefferson
• 16- Constitutional issues in the use of pharmacogenomic variations associated with race / John A. Robertson.

Read “Pharmacogenomics”:

Read “Pharmacogenomics” by choosing from the options below.